Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

ClinicalTrials.gov ID: NCT00637806

Public ClinicalTrials.gov record NCT00637806. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study of Megestrol Acetate Concentrated Suspension for the Treatment of Cancer-associated Anorexia in Subjects With Cancer of Multiple Types

Study identification

NCT ID
NCT00637806
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Par Pharmaceutical, Inc.
Industry
Enrollment
4 participants

Conditions and interventions

Interventions

  • Megestrol acetate concentrated suspension 110 mg/mL Drug
  • Megestrol acetate concentrated suspension 60 mg/mL Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Aug 31, 2006
Completion
Aug 31, 2006
Last update posted
May 1, 2016

2006

United States locations

U.S. sites
4
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
Pacific Cancer Medical Center, Inc. Anaheim California 92801
Four Seasons Hospice and Paliative Care Flat Rock North Carolina 28731
Wake Forest University High Point North Carolina 27262
Summit Oncology Associates, Inc. Akron Ohio 44304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00637806, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2016 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00637806 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →